Opticyte Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
Opticyte General Information
Description
Developer of a cellular oximeter designed to monitor patients' health. The company's noninvasive oximeter uses optical spectroscopy to measure oxygen inside cells and facilitate early detection of shock, enabling clinicians to make treatment decisions to prevent multiple organ failure and death in patients suffering from sepsis, hemorrhage, and cardiac dysfunction.
Contact Information
Website
www.opticyte.comCorporate Office
- 4000 Mason Road
- Suite 300
- Seattle, WA 98195
- United States
Corporate Office
- 4000 Mason Road
- Suite 300
- Seattle, WA 98195
- United States
Opticyte Timeline
Opticyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 10. Equity Crowdfunding | 30-Jun-2025 | Completed | Generating Revenue | |||
| 9. Angel (individual) | 05-Dec-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | Cancelled | Generating Revenue | ||||
| 7. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 6. Seed Round | 01-Oct-2020 | Completed | Generating Revenue | |||
| 5. Grant | 01-May-2020 | Completed | Startup | |||
| 4. Grant | 01-Jan-2016 | Completed | Startup | |||
| 3. Grant | 01-Apr-2015 | $911K | Completed | Startup | ||
| 2. Grant | 01-Jan-2015 | $150K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opticyte Patents
Opticyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260114763-A1 | Determining blood-oxygen level (spo2) using broadband spectra to reduce or eliminate skin-tone bias in the determined spo2 value, and/or using broadband spectra to determine pulse rate | Pending | 29-Oct-2024 | ||
| WO-2026096679-A1 | Determining blood-oxygen level (spo2) using broadband spectra to reduce or eliminate skin-tone bias in the determined spo2 value, and/or using broadband spectra to determine pulse rate | Pending | 29-Oct-2024 | ||
| EP-4727645-A1 | Determining a level of oxygenation of one or more cells | Pending | 15-Jun-2023 | ||
| WO-2024259447-A1 | Determining a level of oxygenation of one or more cells | Inactive | 15-Jun-2023 | ||
| EP-4322852-A1 | Determining a level of oxygenation of one or more cells | Pending | 16-Apr-2021 | A61B5/0075 |
Opticyte Signals
Opticyte Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FBomb Angels | Angel Group | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| Keiretsu Capital | Venture Capital | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| SWAN Venture Fund | Angel Group | Minority |
Opticyte FAQs
-
When was Opticyte founded?
Opticyte was founded in 2015.
-
Where is Opticyte headquartered?
Opticyte is headquartered in Seattle, WA.
-
What is the size of Opticyte?
Opticyte has 9 total employees.
-
What industry is Opticyte in?
Opticyte’s primary industry is Monitoring Equipment.
-
Is Opticyte a private or public company?
Opticyte is a Private company.
-
What is Opticyte’s current revenue?
The current revenue for Opticyte is .
-
How much funding has Opticyte raised over time?
Opticyte has raised $1.78M.
-
Who are Opticyte’s investors?
FBomb Angels, MedTech Innovator, Keiretsu Capital, Keiretsu Forum, and SWAN Venture Fund are 5 of 9 investors who have invested in Opticyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process